Europe PMC requires Javascript to function effectively.
Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.
Comparison of the blood, tumor and muscle uptakes of 89Zr-df-Onartuzumab and 76Br-Onartuzumab in MKN-45 xenografts from 6 h to 5 d. Each bar represents %ID/g ± SD of 89Zr-df-Onartuzumab [(n= 5 (18 h); n=4 (other times) or [76Br]Onartuzumab (n= 4)].